Boussard & Gavaudan Investment Management LLP: Form 8.3

[ad_1] FORM 8.3 PUBLIC DISCLOSURE OF OPENING POSITION / DISCLOSURE OF TREATMENT BY A PERSON WITH INTEREST IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Procurement Code (the “Code”) 1. KEY INFORMATION (a) Identity of the person whose positions / deals are disclosed: Boussard & Gavaudan Investment Management …

Read More »

Form 8.3 – AXA INVESTMENT MANAGERS: Future plc trading

[ad_1] FORM 8.3 PUBLIC DISCLOSURE OF OPENING POSITION / DISCLOSURE OF TREATMENT BY A PERSON WITH INTEREST IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Procurement Code (the “Code”) 1. KEY INFORMATION (a) Full name of the discloser: AXA Investment Managers SA (b) Owner or controller of disclosed …

Read More »

COVID-19 Vaccine Test in India on Jan 2

[ad_1] Vials of AstraZeneca’s COVISHIELD, coronavirus disease (COVID-19) vaccine are seen prior to packaging inside a laboratory at the Serum Institute of India, Pune, India on November 30, 2020. Image Credit: Reuters New Delhi: After the successful completion of the coronavirus vaccination trial in four states, a similar mega drill …

Read More »